The US FDA has accepted Intellia Therapeutics’ application for lonvoguran ziclumeran (lonvo-z, formerly NTLA-2002) and ...

(Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in ...

Delivering CRISPR-Cas9 as mRNA in lipid nanoparticles preserved the fitness and erythroid potential of edited human ...

Global adoption growing with more than 400 institutions across 33 countries ordering DNA constructs up to 49.1 kb, with ...

A gene-edited pig kidney kept a patient with end-stage kidney disease dialysis-free for 271 days, then failed and was removed without leaving the recipient sensitised against human donors. Eighty-two ...

In vivo genome editing is entering an important new phase. Advances in editing technologies, delivery platforms and translational science are bringing the prospect of one-time, directly administered ...

An new end-to-end nomination workflow improves the nomination of genomic sites that may be unintentionally edited by CRISPR-Cas, combining high... Triple Base Editor Diversifies Three Nucleotides... A ...

–ARIA investment advances QBI's landmark Science study, accelerating the path from molecular discovery to new precision ...

A biodegradable charge-altering releasable transporter (CART) delivered RNA selectively to the corneal endothelium after injection into the anterior chamber of mouse eyes. The platform supported ...

Great to see our founder Jens-Ole Bock speaking at this week's CRISPR Gene Editing Hands-on Workshop at University of Lagos - an important reminder ...

Genome-wide CRISPR-Cas9 screens identified hundreds of genes that support or restrict cGAS–STING-induced type I interferon expression in human monocytic cells. The resulting map links interferon ...

CRISPR AgroBio News (CARBON) - an emerging initiative from CRISPR Medicine News - brings you the latest news on how CRISPR can shape agriculture for the future to guarantee food security in times of ...